Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Karavasilis V, Samantas E, Koliou GA, Kalogera-Fountzila A, Pentheroudakis G, Varthalitis I, Linardou H, Rallis G, Skondra M, Papadopoulos G, Papatsibas G, Sgouros J, Goudopoulou A, Kalogeras KT, Dervenis C, Pectasides D, Fountzilas G.

Target Oncol. 2018 Dec;13(6):715-724. doi: 10.1007/s11523-018-0605-y.

PMID:
30488350
2.

AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.

Pentheroudakis G, Kotoula V, Koliou GA, Karavasilis V, Samantas E, Aravantinos G, Kalogeropoulou L, Souglakos I, Kentepozidis N, Koumakis G, Sgouros J, Zarkavelis G, Efstratiou I, Laschos K, Petraki C, Tikas I, Poulios C, Voutsina A, Goudopoulou A, Bafaloukos D, Vrettou E, Kalogera-Fountzila A, Pectasides D, Fountzilas G.

Clin Colorectal Cancer. 2018 Dec;17(4):e631-e637. doi: 10.1016/j.clcc.2018.06.003. Epub 2018 Jun 15.

PMID:
29980490
3.

Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.

Papadopoulou K, Murray S, Manousou K, Tikas I, Dervenis C, Sgouros J, Rontogianni D, Lakis S, Bobos M, Poulios C, Pervana S, Lazaridis G, Fountzilas G, Kotoula V.

Am J Cancer Res. 2018 Jan 1;8(1):2-15. eCollection 2018.

4.

Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report.

Miaris N, Zezas S, Sgouros J, Zirou DC, Gkoura S, Stamoulis G, Angelopoulou H, Avgeropoulos G, Samantas E.

Heart Lung. 2017 Sep - Oct;46(5):382-386. doi: 10.1016/j.hrtlng.2017.06.003. Epub 2017 Jul 18.

PMID:
28733066
5.

Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer.

Miaris N, Sgouros J, Gerolympou M, Spyropoulos B, Drakopoulos D, Gkoura S, Res H, Samantas E.

J Gastrointest Cancer. 2019 Mar;50(1):123-126. doi: 10.1007/s12029-017-9986-x. No abstract available.

PMID:
28660523
6.

Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Kountourakis P, Kyriazanos I, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Ziras N, Souglakos J.

Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416. Epub 2016 Jun 3.

7.

Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Xynos E, Tekkis P, Gouvas N, Vini L, Chrysou E, Tzardi M, Vassiliou V, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Triantopoulou C, Xynogalos S, Karachaliou N, Ziras N, Zoras O, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)].

Ann Gastroenterol. 2016 Apr-Jun;29(2):103-26. doi: 10.20524/aog.2016.0003.

8.

Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.

Xynos E, Gouvas N, Triantopoulou C, Tekkis P, Vini L, Tzardi M, Boukovinas I, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Dervenis C, Emmanouilidis C, Georgiou P, Katopodi O, Kountourakis P, Makatsoris T, Papakostas P, Papamichael D, Pentheroudakis G, Pilpilidis I, Sgouros J, Vassiliou V, Xynogalos S, Ziras N, Karachaliou N, Zoras O, Agalianos C, Souglakos J; [the Executive Team on behalf of the Hellenic Society of Medical Oncology (HeSMO)].

Ann Gastroenterol. 2016 Jan-Mar;29(1):3-17.

9.

Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.

Kountourakis P, Souglakos J, Gouvas N, Androulakis N, Athanasiadis A, Boukovinas I, Christodoulou C, Chrysou E, Dervenis C, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Makatsoris T, Papakostas P, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Xynos E, Ziras N, Papamichael D.

Ann Gastroenterol. 2016 Jan-Mar;29(1):18-23.

10.

Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.

Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):699-706. doi: 10.1016/j.oooo.2015.08.007. Epub 2015 Aug 21. Review.

PMID:
26455289
11.

Impact of Dose Reductions, Delays Between Chemotherapy Cycles, and/or Shorter Courses of Adjuvant Chemotherapy in Stage II and III Colorectal Cancer Patients: a Single-Center Retrospective Study.

Sgouros J, Aravantinos G, Kouvatseas G, Rapti A, Stamoulis G, Bisvikis A, Res H, Samantas E.

J Gastrointest Cancer. 2015 Dec;46(4):343-9. doi: 10.1007/s12029-015-9746-8.

PMID:
26143067
12.

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.

Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, Vrettou E, Sgouros J, Samantas E, Basdanis G, Papakostas P, Bafaloukos D, Kotoula V, Kalofonos HP, Scopa CD, Pentheroudakis G, Fountzilas G.

BMC Cancer. 2015 May 10;15:384. doi: 10.1186/s12885-015-1406-7.

13.

The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.

Strimpakos A, Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Andreadou A, Sgouros J, Zizi-Sermpetzoglou A, Kominea A, Televantou D, Razis E, Galani E, Pectasides D, Tejpar S, Syrigos K, Fountzilas G.

Clin Colorectal Cancer. 2013 Dec;12(4):267-274.e2. doi: 10.1016/j.clcc.2013.07.001. Epub 2013 Sep 17.

PMID:
24050852
14.

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

Pentheroudakis G, Kotoula V, De Roock W, Kouvatseas G, Papakostas P, Makatsoris T, Papamichael D, Xanthakis I, Sgouros J, Televantou D, Kafiri G, Tsamandas AC, Razis E, Galani E, Bafaloukos D, Efstratiou I, Bompolaki I, Pectasides D, Pavlidis N, Tejpar S, Fountzilas G.

BMC Cancer. 2013 Feb 2;13:49. doi: 10.1186/1471-2407-13-49.

15.

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.

Pectasides D, Papaxoinis G, Kalogeras KT, Eleftheraki AG, Xanthakis I, Makatsoris T, Samantas E, Varthalitis I, Papakostas P, Nikitas N, Papandreou CN, Pentheroudakis G, Timotheadou E, Koutras A, Sgouros J, Bafaloukos D, Klouvas G, Economopoulos T, Syrigos KN, Fountzilas G.

BMC Cancer. 2012 Jun 29;12:271. doi: 10.1186/1471-2407-12-271.

16.

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.

Maraveyas A, Waters J, Roy R, Fyfe D, Propper D, Lofts F, Sgouros J, Gardiner E, Wedgwood K, Ettelaie C, Bozas G.

Eur J Cancer. 2012 Jun;48(9):1283-92. doi: 10.1016/j.ejca.2011.10.017. Epub 2011 Nov 17.

PMID:
22100906
17.

Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.

Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, Bozionelou V, Bompolaki I, Sgouros J, Taktikou V, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1389-98. doi: 10.1007/s10096-011-1454-0. Epub 2011 Oct 31.

PMID:
22037822
18.

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab.

Koutras AK, Antonacopoulou AG, Eleftheraki AG, Dimitrakopoulos FI, Koumarianou A, Varthalitis I, Fostira F, Sgouros J, Briasoulis E, Bournakis E, Bafaloukos D, Bompolaki I, Galani E, Kalogeras KT, Pectasides D, Fountzilas G, Kalofonos HP.

Pharmacogenomics J. 2012 Dec;12(6):468-75. doi: 10.1038/tpj.2011.37. Epub 2011 Aug 16.

PMID:
21844885
19.

Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases.

Sgouros J, Cast J, Garadi KK, Belechri M, Breen DJ, Monson JR, Maraveyas A.

World J Gastrointest Oncol. 2011 Apr 15;3(4):60-6. doi: 10.4251/wjgo.v3.i4.60.

20.

Pulmonary Langerhans cell histiocytosis in a patient previously treated for germ cell tumor.

Melexopoulou CA, Sgouros J, Argyriou P, Tsitsimelis D, Aravantinos G, Samantas E.

J BUON. 2010 Jan-Mar;15(1):194-5. No abstract available.

21.

Sinusoidal obstruction syndrome (veno-occlusive disease) in a patient receiving bevacizumab for metastatic colorectal cancer: a case report.

Agarwal V, Sgouros J, Smithson J, Lodge JP, Razack A, Campbell A, Maraveyas A.

J Med Case Rep. 2008 Jul 11;2:227. doi: 10.1186/1752-1947-2-227.

23.

Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.

Sgouros J, Galani E, Gonos E, Moutsatsou P, Belechri M, Skarlos D, Dionyssiou-Asteriou A.

In Vivo. 2007 May-Jun;21(3):519-22.

24.

Correlation of MDR 1 expression and CA 125 in ovarian cancer.

Galani E, Skarlos D, Sgouros J, Litos M, Gonos E, Dionyssiou-Asteriou A.

In Vivo. 2005 Jul-Aug;19(4):797-800.

25.

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

Maraveyas A, Sgouros J, Upadhyay S, Abdel-Hamid AH, Holmes M, Lind M.

Br J Cancer. 2005 Mar 14;92(5):815-9.

26.

Functional recycling of C2 domains throughout evolution: a comparative study of synaptotagmin, protein kinase C and phospholipase C by sequence, structural and modelling approaches.

Jiménez JL, Smith GR, Contreras-Moreira B, Sgouros JG, Meunier FA, Bates PA, Schiavo G.

J Mol Biol. 2003 Oct 24;333(3):621-39.

PMID:
14556749
27.

Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.

Christodoulou C, Klouvas G, Pateli A, Mellou S, Sgouros J, Skarlos DV.

Anticancer Res. 2003 Jan-Feb;23(1B):737-44.

PMID:
12680177
28.
29.

Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.

Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Dionysiou-Asteriou D, Skarlos D, Gonos E.

Anticancer Res. 2002 Jul-Aug;22(4):2275-80.

PMID:
12174914
30.

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas.

Hao XP, Frayling IM, Sgouros JG, Du MQ, Willcocks TC, Talbot IC, Tomlinson IP.

Gut. 2002 Jun;50(6):834-9.

31.

The genome sequence of Schizosaccharomyces pombe.

Wood V, Gwilliam R, Rajandream MA, Lyne M, Lyne R, Stewart A, Sgouros J, Peat N, Hayles J, Baker S, Basham D, Bowman S, Brooks K, Brown D, Brown S, Chillingworth T, Churcher C, Collins M, Connor R, Cronin A, Davis P, Feltwell T, Fraser A, Gentles S, Goble A, Hamlin N, Harris D, Hidalgo J, Hodgson G, Holroyd S, Hornsby T, Howarth S, Huckle EJ, Hunt S, Jagels K, James K, Jones L, Jones M, Leather S, McDonald S, McLean J, Mooney P, Moule S, Mungall K, Murphy L, Niblett D, Odell C, Oliver K, O'Neil S, Pearson D, Quail MA, Rabbinowitsch E, Rutherford K, Rutter S, Saunders D, Seeger K, Sharp S, Skelton J, Simmonds M, Squares R, Squares S, Stevens K, Taylor K, Taylor RG, Tivey A, Walsh S, Warren T, Whitehead S, Woodward J, Volckaert G, Aert R, Robben J, Grymonprez B, Weltjens I, Vanstreels E, Rieger M, Schäfer M, Müller-Auer S, Gabel C, Fuchs M, Düsterhöft A, Fritzc C, Holzer E, Moestl D, Hilbert H, Borzym K, Langer I, Beck A, Lehrach H, Reinhardt R, Pohl TM, Eger P, Zimmermann W, Wedler H, Wambutt R, Purnelle B, Goffeau A, Cadieu E, Dréano S, Gloux S, Lelaure V, Mottier S, Galibert F, Aves SJ, Xiang Z, Hunt C, Moore K, Hurst SM, Lucas M, Rochet M, Gaillardin C, Tallada VA, Garzon A, Thode G, Daga RR, Cruzado L, Jimenez J, Sánchez M, del Rey F, Benito J, Domínguez A, Revuelta JL, Moreno S, Armstrong J, Forsburg SL, Cerutti L, Lowe T, McCombie WR, Paulsen I, Potashkin J, Shpakovski GV, Ussery D, Barrell BG, Nurse P.

Nature. 2002 Feb 21;415(6874):871-80. Erratum in: Nature 2003 Jan 2;421(6918):94. Cerrutti L [corrected to Cerutti L].

PMID:
11859360
32.

The cohesin complex: sequence homologies, interaction networks and shared motifs.

Jones S, Sgouros J.

Genome Biol. 2001;2(3):RESEARCH0009. Epub 2001 Mar 6.

33.

Human DNA repair genes.

Wood RD, Mitchell M, Sgouros J, Lindahl T.

Science. 2001 Feb 16;291(5507):1284-9.

34.

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.

Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ, Watson JE.

Cancer Res. 2000 Mar 15;60(6):1690-7.

35.

Molecular characterization of a human DNA kinase.

Karimi-Busheri F, Daly G, Robins P, Canas B, Pappin DJ, Sgouros J, Miller GG, Fakhrai H, Davis EM, Le Beau MM, Weinfeld M.

J Biol Chem. 1999 Aug 20;274(34):24187-94.

36.

A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein.

Höss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T.

EMBO J. 1999 Jul 1;18(13):3868-75.

37.

Cloning, mapping and expression of UBL3, a novel ubiquitin-like gene.

Chadwick BP, Kidd T, Sgouros J, Ish-Horowicz D, Frischauf AM.

Gene. 1999 Jun 11;233(1-2):189-95.

PMID:
10375635
38.

A relationship betweena DNA-repair/recombination nuclease family and archaeal helicases.

Sgouros J, Gaillard PHL, Wood RD.

Trends Biochem Sci. 1999 Mar;24(3):95-7. No abstract available.

PMID:
10203755
39.

Synaptotagmins: more isoforms than functions?

Schiavo G, Osborne SL, Sgouros JG.

Biochem Biophys Res Commun. 1998 Jul 9;248(1):1-8. Review. No abstract available.

PMID:
9675075
40.

Genomic analysis of the Tapasin gene, located close to the TAP loci in the MHC.

Herberg JA, Sgouros J, Jones T, Copeman J, Humphray SJ, Sheer D, Cresswell P, Beck S, Trowsdale J.

Eur J Immunol. 1998 Feb;28(2):459-67.

41.

Improving community services.

Sgouros J, Moore L.

Nurs Times. 1992 Sep 16-22;88(38):28-30. No abstract available.

PMID:
1408875
42.

A "living fossil" sequence: primary structure of the coelacanth (Latimeria chalumnae) hemoglobin--evolutionary and functional aspects.

Gorr T, Kleinschmidt T, Sgouros JG, Kasang L.

Biol Chem Hoppe Seyler. 1991 Aug;372(8):599-612.

PMID:
1958318
44.

The primary structure of the hemoglobin from the grey-headed flying fox (Pteropus poliocephalus) and the black flying fox (P. alecto, Megachiroptera).

Kleinschmidt T, Sgouros JG, Pettigrew JD, Braunitzer G.

Biol Chem Hoppe Seyler. 1988 Sep;369(9):975-84.

PMID:
3228493
45.

The primary structure of the hemoglobin of the Indian false vampire (Megaderma lyra, Microchiroptera).

Sgouros JG, Kleinschmidt T, Braunitzer G.

Biol Chem Hoppe Seyler. 1988 Jan;369(1):47-53.

PMID:
3348887
46.

The primary structure of the hemoglobin of an Indian flying fox (Cynopterus sphinx, Megachiroptera).

Sgouros JG, Kleinschmidt T, Braunitzer G.

Biol Chem Hoppe Seyler. 1987 Jun;368(6):675-80.

PMID:
3620110
47.

Hemoglobin sequences.

Kleinschmidt T, Sgouros JG.

Biol Chem Hoppe Seyler. 1987 Jun;368(6):579-615. Review. No abstract available.

PMID:
3304337
48.

The primary structure of the hemoglobin of the European marmot (Marmota marmota marmota, Rodentia).

Sgouros JG, Kleinschmidt T, Arnold W, Braunitzer G.

Biol Chem Hoppe Seyler. 1986 Mar;367(3):223-8.

PMID:
3707713

Supplemental Content

Loading ...
Support Center